Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Prev Med. 2021 Dec 1;154:106903. doi: 10.1016/j.ypmed.2021.106903

Table 1.

Characteristics for total sample, and by non-alcoholic fatty liver disease (NAFLD) and subset with advanced fibrosis

Variables Total n=2892 NAFLD (CAP score ≥285 dB/m) Advanced fibrosis (LSM≥ 8.6 kPa)
Yes n=1082 No=1810 p-value Yes n=173 No n=909 p-value
Weighted % ± SE Weighted % ± SE Weighted % ± SE Weighted % ± SE Weighted % ± SE
Age
20–39 68 0.8 .0 48 7.9 .0 20 7.9 .3 < 0.0001 0 3.6 .4 08 6.8 .0 0.23
40–59 06 4.3 .7 89 0.1 .7 17 1.1 .8 8 9.9 .0 31 1.2 .8
60–89 018 4.9 .6 45 2.0 .3 73 1.0 .6 5 6.5 .8 70 3.0 .4
Sex
Male 444 0.1 .3 08 5.7 2.8 36 7.0 .4 < 0.001 09 6.4 .8 99 3.8 .9 0.01
Female 448 9.9 .3 74 4.3 2.8 74 3.0 .4 4 3.6 .8 10 6.2 .9
Race/Ethnicity
Non-Hispanic White 59 0.9 .6 86 1.9 2.8 73 0.4 .0 < 0.0001 4 0.6 .8 22 2.1 .0 0.90
Non-Hispanic Black 88 1.9 .8 90 .3 1.5 98 3.8 .0 7 .4 .8 63 .5 .4
Hispanic 20 7.4 .1 19 0.3 2.7 01 5.7 .9 4 2.2 .6 65 9.9 .0
Other 25 .9 .4 87 .6 1.6 38 0.0 .6 8 .8 .8 59 .5 .6
Education
<12th grade 55 1.1 .0 13 1.6 .5 42 0.8 .0 0.33 78 1.0 .6 5 4.6 .7 0.30
High school + 333 8.9 .0 66 8.4 .5 467 9.2 .0 28 9.0 .6 38 5.4 .7
Household income
<$55,000 417 2.2 1.6 32 1.8 .9 85 2.4 .8 0.85 7 2.9 .3 45 1.6 .1 0.80
≥$55,000 244 7.8 1.6 63 8.2 .9 81 7.6 .8 5 7.1 .3 88 8.4 .1
Smoking
Nonsmoker 724 9.6 .0 04 9.4 .3 120 9.9 .3 0.61 01 3.0 .2 03 8.7 .0 0.02
Former smoker 08 .8 .6 6 .9 .7 2 .3 .9 0.0 .1 0 .1 .5
Current smoker 82 5.4 .7 20 4.8 .3 62 5.8 .1 3 .0 .7 07 6.2 .7
Alcohol Use
No past year use 02 9.9 .0 61 5.7 .6 41 2.9 .5 0.28 0 6.7 .7 01 5.5 .9 0.52
Light-to-Moderate 078 0.6 .7 17 2.2 .0 61 9.7 .9 1 7.2 .9 46 3.1 .8
Heavy Use 11 5.5 .7 04 2.1 .5 07 7.3 .7 2 6.0 .8 62 1.4 .3
Body Mass Index
Under weight/Normal (<25kg/m2) 44 6.4 1.5 5 .8 0.8 79 8.9 .0 < 0.0001 .6 .8 1 .2 .9 < 0.0001
Overweight (2529.9kg/m2) 29 1.3 1.8 01 4.7 3.0 28 4.9 .9 2 .8 .0 79 7.5 .3
Class 1 obesity (3034.9 kg/m2) 34 1.6 1.8 12 8.5 2.7 22 7.7 .8 4 5.1 .7 76 1.0 .1
Class 2 obesity (3539.9 kg/m2) 14 1.4 1.0 03 2.1 2.0 11 .4 .9 7 0.7 .0 66 2.4 .3
Class 3 obesity (>40 kg/m2) 55 .4 1.1 97 0.8 2.6 8 .0 .5 6 2.9 .6 21 4.9 .2
Diabetes
Normal 535 6.6 .2 00 6.7 .9 135 7.5 .6 < 0.0001 0 6.0 .3 60 8.6 .9 < 0.0001
Pre-diabetes 88 0.4 .1 10 7.6 .9 78 6.4 .2 4 6.5 .7 76 9.6 .0
Diabetes 09 3 .9 17 5.6 .3 92 .1 .7 8 7.5 .6 29 1.8 .9
Metabolic Syndrome
Yes 47 6.2 .6 89 8.6 .7 58 3.6 .9 < 0.001 5 4.8 .9 94 5.6 .8 < 0.0001
No 867 3.8 .6 97 1.4 .7 370 6.4 .9 0 5.2 .9 37 4.4 .8
Total energy intake
T1 (<1591 kcal) 11 0.1 .3 90 8.8 .7 21 0.8 .5 0.82 6 5.4 .6 44 9.4 .7 0.35
T2 (1591–2273 kcal) 78 4.9 .3 50 5.6 .7 28 4.5 .6 4 9.3 .3 06 6.6 .0
T3 (≥2273 kcal) 41 5.0 .4 06 5.6 .9 35 4.6 .4 7 5.3 .1 49 4.0 .8
Physical activity
T1 (<4.67 MET hours/week) 050 0.3 .2 46 5.7 .3 04 7.3 .5 < 0.01 7 5.5 .3 79 5.8 .8 0.79
T2 (4.67 – 60 MET hours/week) 17 5.1 .7 19 4.0 .7 98 5.8 .1 3 7.9 .4 56 3.2 .2
T3 (≥60 MET hours/week) 25 4.5 .6 ± 17 0.3 .8 08 6.9 .5 3 6.6 .9 74 0.9 .6
Sedentary Behavior
T1 (<4 hours/day) 06 6.4 .7 13 3.5 .5 93 8.1 .9 0.11 2 1.9 .6 71 3.8 .5 0.18
T2 (4–6 hours/day) 59 6.0 .3 79 5.9 .9 80 6.1 .4 4 8.7 .4 45 7.3 .8
T3 (≥ 6 hours/day) 227 7.5 .0 90 0.6 .1 37 5.9 .4 7 9.4 .8 93 9.0 .2
Healthy Eating Index (HEI)
T1 (<45.6) 45 4.4 .4 40 8.2 .0 05 2.4 .4 0.18 7 2.6 .0 83 7.5 .1 0.78
T2 (45.6–58.5) 41 5.5 .7 00 5.3 .8 41 5.6 .9 8 1.6 .9 52 5.9 .0
T3 (≥58.5) 44 0.1 .4 06 6.5 .4 38 2.1 .9 2 5.8 .6 64 6.6 .5

Notes:

Abbreviations: NAFLD: non-alcoholic fatty liver disease, CAP: controlled attenuation parameter, LSM: liver stiffness measurements, SE: standard error, T: tertile, kcal: kilocalorie, MET: metabolic equivalent.

Models: Chi-Square test or Fisher’s exact test